From: High unacylated ghrelin levels support the concept of anorexia in infants with prader-willi syndrome
 | PWS (nâ=â37) | Controls (nâ=â100) | P valuea |
---|---|---|---|
At birth | |||
âGestational age (weeks) | 37.5 (36.0;39.0) | 39.5 (39.0;39.5) | 0.008 |
âCaesarean delivery (%) | 67Â % | 28Â % | <0.0001 |
âBirth length-z-score | â0.85 (â1.08;â0.60) | â0.29 (â0.56;â0.06) | 0.010 |
âBirth weight-z-score | â1.65 (â1.90;â1.31) | â0.26 (â0.50;â0.02) | <0.0001 |
âBreast feeding (%) | 11 %b | 66Â % | <0.0001 |
âDuration of breast feeding (days) | 92 (45;151) | 135 (99;167) | NS |
At inclusion | |||
âAge (years) | 1.8 (1.4;2.3) | 2.0 (1.7;2.2) | NS |
âSex ratio (% male) | 57Â % | 49Â % | NS |
âHeight-z-score | â0.84 (â1.23;â0.48) | 0.53 (0.25;0.80) | <0.0001 |
âWeight-z-score | â1.06 (â1.49;â0.64) | 0.06 (â0.20;0.35) | <0.0001 |
âBMI-z-score | â0.86 (â1.31;â0.32) | â0.40 (â0.70;â0.10) | NS |
âGH treatment (%) | 68Â % | NA | NA |
âAge at start of GH treatment (months) | 13.0 (11.0;15.5) | NA | NA |
âGH dose (mcg/kg/d) | 0.029 (0.027;0.031) | NA | NA |
âIGF-I (ng/ml) | 98 (61;135) | NA | NA |
âInsulin (pg/ml) | 167 (141;194) | 178 (160;196) | NS |
PWS features | |||
âAge at genetic diagnosis (months) | 1.0 (0.5;2.5) | Â | |
âType of genetic diagnosis (%) | |||
ââDeletion | 24Â % | ||
ââMaternal disomy | 51Â % | ||
ââTranslocation | 3Â % | ||
ââImprinting defect | 11Â % | ||
ââAbnormal methylation profile | 11Â % | ||
Nutritional phase at inclusion | |||
â1a [%âage (months(range))] | 43Â %â4 (2;23) | ||
â1b [%âage (months(range))] | 20Â %â29 (11;45) | ||
â2a [%âage (months(range))] | 23Â %â38 (21;46) | ||
â2b [%âage (months(range))] | 14Â %â34 (26;37) |